Cargando…
Renin–Angiotensin System Implications to COVID-19 Comorbidities
The role of the renin–angiotensin system (RAS) and its pharmacological modulators in the susceptibility and outcomes of SARS CoV-2 pandemic (COVID-19) has been much discussed recently. Angiotensin-converting enzyme type 2 (ACE2) has attracted much attention and debate in relevance to COVID-19. It no...
Autores principales: | Alsufyani, Hadeel A., Alrefaie, Zienab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883491/ https://www.ncbi.nlm.nih.gov/pubmed/33623738 http://dx.doi.org/10.4103/jmau.jmau_105_20 |
Ejemplares similares
-
The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020) -
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020) -
COVID-19 and the Renin Angiotensin System: Implications for the Older Adults
por: Bahat, Gülistan
Publicado: (2020) -
Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
por: Amraei, Razie, et al.
Publicado: (2020)